SCHEMBL1775634

SCHEMBL1775634

O=C1CC[C@@H](CNc2ccc(F)c(F)c2)N1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.42
DDB1 Q16531 1/20 0.42
CD274 Q9NZQ7 8/20 0.38
PDCD1LG2 Q9BQ51 7/20 0.38
KCNA5 P22460 3/20 0.37
TACR1 P25103 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35
PDCD1 Q15116 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27738367 0.84 CRBN (0.47) CRBNDDB1CD274PDCD1LG2KCNA5
SCHEMBL1776611 0.84 CRBN (0.47) CRBNDDB1CD274PDCD1LG2KCNA5
SCHEMBL1777213 0.82 KCNA5 (0.46) CD274PDCD1LG2KCNA5IRAK4PDCD1
SCHEMBL27738355 0.82 KCNA5 (0.46) CD274PDCD1LG2KCNA5IRAK4PDCD1
SCHEMBL1776281 0.81 CD274 (0.40) CD274PDCD1LG2KCNA5TACR1IRAK4
SCHEMBL1777915 0.78 ALDH1A1 (0.40) CRBNDDB1CD274PDCD1LG2SMN1; SMN2
SCHEMBL1776113 0.77 DDB1 (0.44) CRBNDDB1CD274PDCD1LG2KCNA5
SCHEMBL1776665 0.77 TACR1 (0.45) CRBNDDB1CD274PDCD1LG2TACR1
SCHEMBL1776764 0.77 CNR1 (0.41) CRBNDDB1CD274PDCD1LG2KCNA5
SCHEMBL1776850 0.77 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US claimed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 EP claimed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO claimed
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 EP disclosed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD CRBN 814/4885DDB1 3906/4885CD274 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.